ARCHIVES

Translation Of “New Biology” Into Clinical Use Identified By DeVita As NCI’s Major Challenge

This article is from The Cancer Letter archive.

Vol. 11 No. 33 | August 16, 1985

Download PDF Visit The Full Archive

Related Articles

FDA Opponents Claim Abuses; Agency Doesn’t Attend Hearing

July 28, 1995

DCCR Plans Three Multiple Contracts In Pain Control

February 17, 1978

King Named Lombardi Center Deputy Director; SWOG Needs New Exec; Murphy Leaves St. Jude

July 22, 1988

Scientists Lose Credibility When “Fire Alarm” Pulled Too Early, ACS’s Brawley Says.

August 1, 2008

NCI Raises R01 Payline To 16th Percentile FY09. Coalition Formed To Advocate For Medical Innovation

March 27, 2009

Oral Capecitabine Equal To 5FU-Leucovorin In Adjuvant Stage III Colon Cancer Treatment

June 25, 2004